Administration of anabolic steroids appears to result in a small increase in both lean body mass and body weight as compared with placebo in HIV infected individuals.
A Cochrane review 1 included 13 studies with a total of 819 subjects. The average change in lean body mass was 1.3 kg (95% CI: 0.6, 2.0), while the average change in total body weight was 1.1 kg (95% CI: 0.3, 2.0). Significant heterogeneity was present for both outcomes. Four deaths occurred in both the anabolic steroid and placebo treatment groups during the treatment period. There was no difference for withdrawals or discontinuations of study medication due to adverse events.
1. Johns K, Beddall MJ, Corrin RC. Anabolic steroids for the treatment of weight loss in HIV-infected individuals. Cochrane Database Syst Rev 2005 Oct 19;(4):CD005483. [PMID:16235407]
Copyright © 2020 Duodecim Medical Publications Limited.
Anabolic steroids for weight loss in HIV-infected individuals
is a sample topic from the Evidence-Based Medicine Guidelines
To view other topics, please sign in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Complete Product Information.
"Anabolic Steroids for Weight Loss in HIV-infected Individuals." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/456899/all/Anabolic_steroids_for_weight_loss_in_HIV_infected_individuals.
Anabolic steroids for weight loss in HIV-infected individuals. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/456899/all/Anabolic_steroids_for_weight_loss_in_HIV_infected_individuals. Accessed October 31, 2020.
Anabolic steroids for weight loss in HIV-infected individuals. (2019). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. Retrieved October 31, 2020, from https://evidence.unboundmedicine.com/evidence/view/EBMG/456899/all/Anabolic_steroids_for_weight_loss_in_HIV_infected_individuals
Anabolic Steroids for Weight Loss in HIV-infected Individuals [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2020 October 31]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/456899/all/Anabolic_steroids_for_weight_loss_in_HIV_infected_individuals.
TY - ELEC
T1 - Anabolic steroids for weight loss in HIV-infected individuals
ID - 456899
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/456899/all/Anabolic_steroids_for_weight_loss_in_HIV_infected_individuals
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine